Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 6Head & Neck 5Plasma cell 4Genitourinary 4Classical hematology 4Thoracic 3Other hematologic neoplasm 3Other 3Myeloid 3Gynecologic 3Gastrointestinal 3Sarcoma 2Lymphoid 2Dermatologic 1

Conditions

Melanoma 467Skin Neoplasms 144Carcinoma, Basal Cell 94Breast Neoplasms 78Neoplasms 68Lymphoma, T-Cell, Cutaneous 62Lung Neoplasms 57Carcinoma, Squamous Cell 40Carcinoma, Non-Small-Cell Lung 40Mycosis Fungoides 39Uveal Melanoma 38Sezary Syndrome 37Lymphoma, Non-Hodgkin 35Lymphoma 35Keratosis, Actinic 35Pancreatic Neoplasms 34Sarcoma 33Prostatic Neoplasms 33Head and Neck Neoplasms 33Colorectal Neoplasms 33Leukemia, Lymphocytic, Chronic, B-Cell 31Ovarian Neoplasms 30Urinary Bladder Neoplasms 29Multiple Myeloma 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Lymphoma, B-Cell, Marginal Zone 28Colonic Neoplasms 28Lymphoma, Mantle-Cell 27Lymphoma, Follicular 27Leukemia 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Hypersensitivity × Dermatologic × Clear all
NCT06279143 2026-05-26

dOCT-pBCC

Vejle Hospital

Completed
210 enrolled
Dermatologic

Carcinoma, Carcinoma, Basal Cell, Eyelid Diseases, Eyelid Neoplasms, Hypersensitivity, Neoplasms, Glandular and Epithelial, Recurrence, Skin Diseases, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡